All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe
Advertisement

News

Article

July 2, 2008

Pharmaceutical Technology

Pharmaceutical Technology-07-02-2008
Volume32
Issue 7

Trends: Industry Job Cuts

Author(s):

Angie Drakulich

Staff reductions are not surprising with the state of the economy and falling pharmaceutical sales.

Given the current state of the economy and the fact that pharmaceutical sales have been crunched over the past several years, job cuts are not surprising. The US unemployment rate has gone up a full percentage point in the past year, from 4.5% in May 2007 to 5.5% in May 2008; the rate in New Jersey went up from 4.3% to 5.0%. Below is a look at some of the largest cuts that pharmaceutical companies—nearly half of them based in New Jersey—have announced since early 2007.

(Raymond Medici/Getty Images, Cartesia/Getty Images)

Companies and announced job cuts

Articles in this issue

i4-529446-1408663877654.gif
Coming Down the Pike: Protein-Substrate Binding
i4-529447-1408663874222.gif
Trends: Industry Job Cuts
Self-Emulsifying Drug Delivery Systems
A Path to Quality and Compliance
i4-529167-1408664199947.jpg
Improved Mass Determination of Poly(ethylene glycols) by Electrospray Ion-Mobility Time-of-Flight Mass Spectrometry Coupled with Ion–Molecule Reactions
head-529177-1408664159588.gif
Excipients in Polymeric Drug Delivery and Formulations

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
 Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Tariffs & Trade Policy: Results of a Bio/Pharma Peer Survey
Related Content
Advertisement
Lung with tuberculosis, long covid or asthma disease, cancer cells, virus and air pollution, no tobacco day, organ donation | Image Credit: © Berit Kessler - stock.adobe.com
August 28th 2025

Cereno Scientific’s PAH Treatment Gets FDA Fast Track Status

Patrick Lavery
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 28th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Digital Transformation in Pharma Manufacturing: Industry Perspectives Survey
August 28th 2025

Digital Transformation in Pharma Manufacturing: Industry Perspectives Survey

Christopher Cole
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 28th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Specification Equivalence: A Practical Approach to Method and Acceptance Criteria Equivalence
August 28th 2025

Specification Equivalence: A Practical Approach to Method and Acceptance Criteria Equivalence

Gail Reed Joseph A. Albanese Yelena Ionova J. Mark Wiggins
Feb 19, 2020 Foster City / CA / USA - Gilead sign at their headquarters in Silicon Valley; Gilead Sciences, Inc. is an American biotechnology company that researches, develops and commercializes drugs | Image Credit: © Sundry Photography - stock.adobe.com
August 28th 2025

Gilead Sciences’ HIV PrEP Injectable Approved by European Commission

Patrick Lavery
Related Content
Advertisement
Lung with tuberculosis, long covid or asthma disease, cancer cells, virus and air pollution, no tobacco day, organ donation | Image Credit: © Berit Kessler - stock.adobe.com
August 28th 2025

Cereno Scientific’s PAH Treatment Gets FDA Fast Track Status

Patrick Lavery
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 28th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
Digital Transformation in Pharma Manufacturing: Industry Perspectives Survey
August 28th 2025

Digital Transformation in Pharma Manufacturing: Industry Perspectives Survey

Christopher Cole
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 28th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Specification Equivalence: A Practical Approach to Method and Acceptance Criteria Equivalence
August 28th 2025

Specification Equivalence: A Practical Approach to Method and Acceptance Criteria Equivalence

Gail Reed Joseph A. Albanese Yelena Ionova J. Mark Wiggins
Feb 19, 2020 Foster City / CA / USA - Gilead sign at their headquarters in Silicon Valley; Gilead Sciences, Inc. is an American biotechnology company that researches, develops and commercializes drugs | Image Credit: © Sundry Photography - stock.adobe.com
August 28th 2025

Gilead Sciences’ HIV PrEP Injectable Approved by European Commission

Patrick Lavery
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.